Scott L. Carter

86.9k total citations · 6 hit papers
133 papers, 15.1k citations indexed

About

Scott L. Carter is a scholar working on Pulmonary and Respiratory Medicine, Computer Vision and Pattern Recognition and Human-Computer Interaction. According to data from OpenAlex, Scott L. Carter has authored 133 papers receiving a total of 15.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 21 papers in Computer Vision and Pattern Recognition and 21 papers in Human-Computer Interaction. Recurrent topics in Scott L. Carter's work include Cancer Genomics and Diagnostics (19 papers), Personal Information Management and User Behavior (12 papers) and Usability and User Interface Design (12 papers). Scott L. Carter is often cited by papers focused on Cancer Genomics and Diagnostics (19 papers), Personal Information Management and User Behavior (12 papers) and Usability and User Interface Design (12 papers). Scott L. Carter collaborates with scholars based in United States, United Kingdom and Finland. Scott L. Carter's co-authors include Gad Getz, Hui Shen, Peter W. Laird, Douglas A. Levine, Kosuke Yoshihara, Hoon Kim, Katherine Stemke‐Hale, Wandaliz Torres‐García, Emmanuel Martínez and Roel G.W. Verhaak and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Clinical Investigation.

In The Last Decade

Scott L. Carter

125 papers receiving 14.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inferring tumour purity and stromal and immune cell admixture from expression data

2013 6.1k citations Scott L. Carter, Gad Getz et al. profile →
Pan-cancer patterns of somatic copy number alteration

2013 1.2k citations Travis Zack, Steven E. Schumacher et al. Nature Genetics profile →
Absolute quantification of somatic DNA alterations in human cancer

2012 1.1k citations Scott L. Carter, Kristian Cibulskis et al. Nature Biotechnology profile →
A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers

2006 854 citations Scott L. Carter, Aron C. Eklund et al. Nature Genetics profile →
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers

2013 832 citations Michael S. Lawrence, Scott L. Carter et al. Nature Genetics profile →
Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma

2017 361 citations Suzanne George, Diana Miao et al. Immunity profile →

Peers

Countries citing papers authored by Scott L. Carter

Since Specialization

Citations

This map shows the geographic impact of Scott L. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott L. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott L. Carter more than expected).

Fields of papers citing papers by Scott L. Carter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott L. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott L. Carter. The network helps show where Scott L. Carter may publish in the future.

Co-authorship network of co-authors of Scott L. Carter

This figure shows the co-authorship network connecting the top 25 collaborators of Scott L. Carter. A scholar is included among the top collaborators of Scott L. Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott L. Carter. Scott L. Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Secondary Data Sources 2021 ·Maike Rentel, (unknown), (unknown), Scott L. Carter, Margaret Lehman Blake, (unknown), (unknown), Péter Várnai	1
2	Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases 2020 ·Future Oncology ·Alexandra S. Zimmer, Seth M. Steinberg, Dee Dee Smart, Mark R. Gilbert, Terri S. Armstrong, Eric Burton, Nicole Houston, Nadia Biassou, Brunilde Gril, Priscilla K. Brastianos, Scott L. Carter, David Lyden, Stanley Lipkowitz, Patricia S. Steeg	21
3	Effect of very low-protein diets supplemented with branched-chain amino acids on energy balance, plasma metabolomics and fecal microbiome of pigs 2020 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), Udaya DeSilva, Scott L. Carter, Adel Pezeshki	47
4	The Dual PI3K/mTOR Pathway Inhibitor GDC-0084 Achieves Antitumor Activity in PIK3CA -Mutant Breast Cancer Brain Metastases 2019 ·Clinical Cancer Research ·Franziska M. Ippen, Christopher Alvarez‐Breckenridge, Benjamin M. Kuter, Alexandria L. Fink, Ivanna V. Bihun, Matthew Lastrapes, Tristan Penson, Stephen Schmidt, Gregory R. Wojtkiewicz, Jianfang Ning, Megha Subramanian, Anita Giobbie‐Hurder, María Martínez-Lage, Scott L. Carter, Daniel P. Cahill, Hiroaki Wakimoto, Priscilla K. Brastianos	61
5	Genomic Evolutionary Patterns of Leiomyosarcoma and Liposarcoma 2019 ·Clinical Cancer Research ·Ali Amin‐Mansour, Suzanne George, Stefano Sioletic, Scott L. Carter, Mara Rosenberg, Amaro Taylor‐Weiner, Chip Stewart, Aaron Chevalier, Sara Seepo, Adam Tracy, Gad Getz, Jason L. Hornick, Marisa R. Nucci, Bradley J. Quade, George D. Demetri, Chandrajit P. Raut, Levi A. Garraway, Eliezer M. Van Allen, Andrew J. Wagner	18
6	Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer 2019 ·Clinical Cancer Research ·Sophia C. Kamran, Jochen K. Lennerz, Claire A. Margolis, David Liu, Brendan Reardon, Stephanie A. Wankowicz, Emily E. Van Seventer, Adam Tracy, Jennifer Y. Wo, Scott L. Carter, Henning Willers, Ryan B. Corcoran, Theodore S. Hong, Eliezer M. Van Allen	62
7	Detection of Mutations in Barrett’s Esophagus Before Progression to High-Grade Dysplasia or Adenocarcinoma 2018 ·Gastroenterology ·Matthew D. Stachler, Nicholas D. Camarda, Christopher Deitrick, Anthony Kim, Agoston T. Agoston, Robert D. Odze, Jason L. Hornick, Anwesha Nag, Aaron R. Thorner, Matthew D. Ducar, Amy Noffsinger, Richard H. Lash, Mark Redston, Scott L. Carter, Jon M. Davison, Adam J. Bass	97
8	Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma breakdown → 2017 ·Immunity ·Suzanne George, Diana Miao, George D. Demetri, Dennis O. Adeegbe, Scott J. Rodig, Sachet A. Shukla, Mikel Lipschitz, Ali Amin‐Mansour, Chandrajit P. Raut, Scott L. Carter, Peter S. Hammerman, Gordon J. Freeman, Catherine J. Wu, Patrick A. Ott, Kwok‐Kin Wong, Eliezer M. Van Allen	361
9	Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma 2016 ·Clinical Cancer Research ·Kent W. Mouw, James M. Cleary, Brendan Reardon, (unknown), Lior Z. Braunstein, Jaegil Kim, Ali Amin‐Mansour, Diana Miao, (unknown), Joanna Chin, Patrick A. Ott, Charles S. Fuchs, Neil E. Martin, Gad Getz, Scott L. Carter, Harvey J. Mamon, Jason L. Hornick, Eliezer M. Van Allen, Alan D. D’Andrea	36
10	Landscape of Genomic Alterations in Pituitary Adenomas 2016 ·Clinical Cancer Research ·Wenya Linda Bi, Peleg Horowitz, Noah F. Greenwald, Malak Abedalthagafi, Pankaj K. Agarwalla, William J. Gibson, Yu Mei, Steven E. Schumacher, Uri Ben‐David, Aaron Chevalier, Scott L. Carter, Grace Tiao, Priscilla K. Brastianos, Azra H. Ligon, (unknown), Laura E. MacConaill, Edward R. Laws, Sandro Santagata, Rameen Beroukhim, Ian F. Dunn	88
11	Genomic evolution and chemoresistance in germ-cell tumours 2016 ·Nature ·Amaro Taylor‐Weiner, Travis Zack, Elizabeth O’Donnell, Jennifer L. Guerriero, Brandon Bernard, Anita Reddy, G. Celine Han, Saud H. AlDubayan, Ali Amin‐Mansour, Steven E. Schumacher, Kevin Litchfield, Clare Turnbull, Stacey Gabriel, Rameen Beroukhim, Gad Getz, Scott L. Carter, Michelle S. Hirsch, Anthony Letai, Christopher J. Sweeney, Eliezer M. Van Allen	114
12	Brain Metastasis: Clinical Implications of Branched Evolution 2016 ·Trends in cancer ·Ibiayi Dagogo‐Jack, Scott L. Carter, Priscilla K. Brastianos	10
13	An investigation into the relationship between age and physiological function in highly active older adults 2015 ·The Journal of Physiology ·Ross D. Pollock, Scott L. Carter, Cristiana P. Velloso, Niharika A. Duggal, Janet M. Lord, Norman R. Lazarus, Stephen D. R. Harridge	87
14	Response and Acquired Resistance to Everolimus in Anaplastic Thyroid Cancer 2014 ·New England Journal of Medicine ·Nikhil Wagle, Brian C. Grabiner, Eliezer M. Van Allen, Ali Amin‐Mansour, Amaro Taylor‐Weiner, Mara Rosenberg, Nathanael S. Gray, Justine A. Barletta, Junming Guo, Steven Swanson, Daniel T. Ruan, Glenn J. Hanna, Robert I. Haddad, Gad Getz, David J. Kwiatkowski, Scott L. Carter, David M. Sabatini, Pasi A. Jänne, Levi A. Garraway, Jochen H. Lorch	234
15	Resistance to CDK2 Inhibitors Is Associated with Selection of Polyploid Cells in CCNE1 -Amplified Ovarian Cancer 2013 ·Clinical Cancer Research ·Dariush Etemadmoghadam, George Au‐Yeung, Meaghan Wall, Thomas J. Mitchell, Maya Kansara, Elizabeth Loehrer, (unknown), Joshy George, Sarah Ftouni, Barbara A. Weir, Scott L. Carter, Irma Gresshoff, Linda Mileshkin, Danny Rischin, William C. Hahn, Paul Waring, Gad Getz, Carleen Cullinane, Lynda J. Campbell, David D.L. Bowtell	90
16	Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples 2013 ·Nature Biotechnology ·Kristian Cibulskis, Michael S. Lawrence, Scott L. Carter, Andrey Sivachenko, David B. Jaffe, Carrie Sougnez, (unknown), Matthew Meyerson, Eric S. Lander, Gad Getz	223
17	Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability 2012 ·Genome Research ·Yotam Drier, Michael S. Lawrence, Scott L. Carter, Chip Stewart, Stacey Gabriel, Eric S. Lander, Matthew Meyerson, Rameen Beroukhim, Gad Getz	86
18	A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers breakdown → 2006 ·Nature Genetics ·Scott L. Carter, Aron C. Eklund, Isaac S. Kohane, Lyndsay N. Harris, Zoltán Szállási	854
19	Redefinition of Affymetrix probe sets by sequence overlap with cDNA microarray probes reduces cross-platform inconsistencies in cancer-associated gene expression measurements 2005 ·BMC Bioinformatics ·Scott L. Carter, Aron C. Eklund, Brigham H. Mecham, Isaac S. Kohane, Zoltán Szállási	98
20	Abundance, diversity, and patterns of distribution of primates on the Tapiche River in Amazonian Peru 2001 ·American Journal of Primatology ·Cynthia Bennett, (unknown), Scott L. Carter	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact